» Articles » PMID: 21163900

Enteric Oxalate Elimination is Induced and Oxalate is Normalized in a Mouse Model of Primary Hyperoxaluria Following Intestinal Colonization with Oxalobacter

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Oxalobacter colonization of rat intestine was previously shown to promote enteric oxalate secretion and elimination, leading to significant reductions in urinary oxalate excretion (Hatch et al. Kidney Int 69: 691-698, 2006). The main goal of the present study, using a mouse model of primary hyperoxaluria type 1 (PH1), was to test the hypothesis that colonization of the mouse gut by Oxalobacter formigenes could enhance enteric oxalate secretion and effectively reduce the hyperoxaluria associated with this genetic disease. Wild-type (WT) mice and mice deficient in liver alanine-glyoxylate aminotransferase (Agxt) exhibiting hyperoxalemia and hyperoxaluria were used in these studies. We compared the unidirectional and net fluxes of oxalate across isolated, short-circuited large intestine of artificially colonized and noncolonized mice. In addition, plasma and urinary oxalate was determined. Our results demonstrate that the cecum and distal colon contribute significantly to enteric oxalate excretion in Oxalobacter-colonized Agxt and WT mice. In colonized Agxt mice, urinary oxalate excretion was reduced 50% (to within the normal range observed for WT mice). Moreover, plasma oxalate concentrations in Agxt mice were also normalized (reduced 50%). Colonization of WT mice was also associated with marked (up to 95%) reductions in urinary oxalate excretion. We conclude that segment-specific effects of Oxalobacter on intestinal oxalate transport in the PH1 mouse model are associated with a normalization of plasma oxalate and urinary oxalate excretion in otherwise hyperoxalemic and hyperoxaluric animals.

Citing Articles

Efficacy and safety of in patients with primary hyperoxaluria: A systematic review and meta-analysis of randomized controlled trials.

Khan U, Mubariz M, Rezq H, Mahmoud A, Moiz Nasir M, Ain N Indian J Urol. 2025; 41(1):11-19.

PMID: 39886625 PMC: 11778695. DOI: 10.4103/iju.iju_359_24.


Complex system modelling reveals oxalate homeostasis is driven by diverse oxalate-degrading bacteria.

Mukherjee S, Batagello C, Adler A, Agudelo J, Zampini A, Suryavanshi M bioRxiv. 2024; .

PMID: 39553961 PMC: 11565779. DOI: 10.1101/2024.10.28.620613.


Digesting the complex metabolic effects of diet on the host and microbiome.

Carmody R, Varady K, Turnbaugh P Cell. 2024; 187(15):3857-3876.

PMID: 39059362 PMC: 11309583. DOI: 10.1016/j.cell.2024.06.032.


Deficient butyrate metabolism in the intestinal microbiome is a potential risk factor for recurrent kidney stone disease.

Choy W, Adler A, Morgan-Lang C, Gough E, Hallam S, Manges A Urolithiasis. 2024; 52(1):38.

PMID: 38413462 DOI: 10.1007/s00240-024-01534-x.


Oxalate Nephropathy and the Mechanism of Oxalate-Induced Kidney Injury.

Bao D, Wang Y, Zhao M Kidney Dis (Basel). 2023; 9(6):459-468.

PMID: 38089442 PMC: 10712969. DOI: 10.1159/000533295.


References
1.
Belostotsky R, Seboun E, Idelson G, Milliner D, Becker-Cohen R, Rinat C . Mutations in DHDPSL are responsible for primary hyperoxaluria type III. Am J Hum Genet. 2010; 87(3):392-9. PMC: 2933339. DOI: 10.1016/j.ajhg.2010.07.023. View

2.
Monico C, Milliner D . Combined liver-kidney and kidney-alone transplantation in primary hyperoxaluria. Liver Transpl. 2001; 7(11):954-63. DOI: 10.1053/jlts.2001.28741. View

3.
Sidhu H, Hoppe B, Hesse A, Tenbrock K, Bromme S, Rietschel E . Absence of Oxalobacter formigenes in cystic fibrosis patients: a risk factor for hyperoxaluria. Lancet. 1998; 352(9133):1026-9. DOI: 10.1016/S0140-6736(98)03038-4. View

4.
Freel R, Hatch M, Green M, Soleimani M . Ileal oxalate absorption and urinary oxalate excretion are enhanced in Slc26a6 null mice. Am J Physiol Gastrointest Liver Physiol. 2005; 290(4):G719-28. DOI: 10.1152/ajpgi.00481.2005. View

5.
Jiang Z, Asplin J, Evan A, Rajendran V, Velazquez H, Nottoli T . Calcium oxalate urolithiasis in mice lacking anion transporter Slc26a6. Nat Genet. 2006; 38(4):474-8. DOI: 10.1038/ng1762. View